Public trading strategy
Defensive growth shines as rate fears ease — ride Eli Lilly's GLP-1 dominance
Created
Thesis
Eli Lilly has a fundamental catalyst with Medicare inclusion for GLP-1 drugs, effectively guaranteeing a massive new revenue stream. The stock is hitting highs just as the weak jobs report takes the threat of rate hikes off the table. High-growth, defensive stocks like pharmaceutical companies thrive when rates are stable because their future earnings become more valuable. This creates a perfect environment to buy the momentum in LLY.
Strategy approach
Build a breakout strategy that enters long LLY on D1 when the stock closes within 1% of its 20-day high and the broader market ETF (SPY) is also closing green for the day. Exit if LLY drops 5% from its entry point or after a 21-day holding period.
Markets and timeframes
LLYD1
Entry and exit at a glance
These are the named rules in the shared configuration. Review the full conditions below before using a strategy.
- Entry: DONCHIAN/EMA/ADX Crossover Long (SPY@1d) (6 conditions)
- Exit: Stop Loss at 2.3% (1 condition)
- Exit: Take Profit at 4.5% (1 condition)
- Exit: TP: Fib Extension 127.2% (SPY@1d) (1 condition)
- Exit: SL: Below Support[1] (SPY@1d) (1 condition)
Shared strategy rules
Rule configuration
{
"data_dependencies": [
{
"symbol": "SPY",
"timeframe": "1d"
}
],
"entry_rules": [
{
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"field": "upper",
"indicator": {
"name": "donchian",
"period": 20
},
"type": "indicator"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "less_than",
"right": {
"type": "constant",
"value": 1
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"field": "open",
"type": "price"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "resistance_level"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"indicator": {
"name": "ema",
"period": 10
},
"type": "indicator"
}
},
{
"left": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"field": "adx",
"indicator": {
"name": "adx",
"period": 14
},
"type": "indicator"
},
"operator": "greater_than",
"right": {
"type": "constant",
"value": 20
}
}
],
"direction": "long",
"enabled": true,
"id": "entry_1",
"name": "DONCHIAN/EMA/ADX Crossover Long (SPY@1d)",
"priority": 1,
"trade_symbol": "SPY"
}
],
"exit_rules": [
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "unrealized_pnl_percent",
"type": "position"
},
"operator": "less_than_or_equal",
"right": {
"type": "constant",
"value": -2.268846153846154
}
}
],
"enabled": true,
"id": "exit_1",
"name": "Stop Loss at 2.3%",
"priority": 100,
"purpose": "stop_loss"
},
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "unrealized_pnl_percent",
"type": "position"
},
"operator": "greater_than_or_equal",
"right": {
"type": "constant",
"value": 4.537692307692308
}
}
],
"enabled": true,
"id": "exit_2",
"name": "Take Profit at 4.5%",
"priority": 100,
"purpose": "take_profit"
},
{
"applies_to": "long",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than_or_equal",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"ratio": 1272,
"type": "fibonacci_extension"
}
}
],
"enabled": true,
"id": "exit_3",
"name": "TP: Fib Extension 127.2% (SPY@1d)",
"priority": 97,
"purpose": "take_profit"
},
{
"applies_to": "long",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "support_level"
}
}
],
"enabled": true,
"id": "exit_4",
"name": "SL: Below Support[1] (SPY@1d)",
"priority": 100,
"purpose": "stop_loss"
}
],
"position_sizing": {
"max_position_percent": 25,
"method": {
"risk_percent": 2.268846153846154,
"support_stop_rank": 1,
"type": "fixed_risk"
},
"min_position_value": 100
},
"trigger_timeframe": "1d",
"version": 1
}Indicator configuration
{
"indicators": [
{
"name": "donchian",
"period": 20
},
{
"name": "ema",
"period": 10
},
{
"name": "ema",
"period": 20
},
{
"name": "adx",
"period": 14
}
]
}Parsed strategy
{
"data_dependencies": [
{
"symbol": "SPY",
"timeframe": "1d"
}
],
"entry_rules": [
{
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"field": "upper",
"indicator": {
"name": "donchian",
"period": 20
},
"type": "indicator"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "less_than",
"right": {
"type": "constant",
"value": 1
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"field": "open",
"type": "price"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "resistance_level"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"indicator": {
"name": "ema",
"period": 10
},
"type": "indicator"
}
},
{
"left": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"field": "adx",
"indicator": {
"name": "adx",
"period": 14
},
"type": "indicator"
},
"operator": "greater_than",
"right": {
"type": "constant",
"value": 20
}
}
],
"direction": "long",
"enabled": true,
"id": "entry_1",
"name": "DONCHIAN/EMA/ADX Crossover Long (SPY@1d)",
"priority": 1,
"trade_symbol": "SPY"
}
],
"exit_rules": [
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "unrealized_pnl_percent",
"type": "position"
},
"operator": "less_than_or_equal",
"right": {
"type": "constant",
"value": -2.268846153846154
}
}
],
"enabled": true,
"id": "exit_1",
"name": "Stop Loss at 2.3%",
"priority": 100,
"purpose": "stop_loss"
},
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "unrealized_pnl_percent",
"type": "position"
},
"operator": "greater_than_or_equal",
"right": {
"type": "constant",
"value": 4.537692307692308
}
}
],
"enabled": true,
"id": "exit_2",
"name": "Take Profit at 4.5%",
"priority": 100,
"purpose": "take_profit"
},
{
"applies_to": "long",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than_or_equal",
"right": {
"chart_ref": {
"symbol": "SPY",
"timeframe": "1d"
},
"ratio": 1272,
"type": "fibonacci_extension"
}
}
],
"enabled": true,
"id": "exit_3",
"name": "TP: Fib Extension 127.2% (SPY@1d)",
"priority": 97,
"purpose": "take_profit"
},
{
"applies_to": "long",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "support_level"
}
}
],
"enabled": true,
"id": "exit_4",
"name": "SL: Below Support[1] (SPY@1d)",
"priority": 100,
"purpose": "stop_loss"
}
],
"position_sizing": {
"max_position_percent": 25,
"method": {
"risk_percent": 2.268846153846154,
"support_stop_rank": 1,
"type": "fixed_risk"
},
"min_position_value": 100
},
"trigger_timeframe": "1d",
"version": 1
}Strategy instructions
Trading agent generated from recommendation idea 'Defensive growth shines as rate fears ease — ride Eli Lilly's GLP-1 dominance'. Thesis: Eli Lilly has a fundamental catalyst with Medicare inclusion for GLP-1 drugs, effectively guaranteeing a massive new revenue stream. The stock is hitting highs just as the weak jobs report takes the threat of rate hikes off the table. High-growth, defensive stocks like pharmaceutical companies thrive when rates are stable because their future earnings become more valuable. This creates a perfect environment to buy the momentum in LLY.
Performance
No trade count, win rate, or realized P&L figures are provided in this public preview. The thesis and shared rules do not establish a performance record.
What this public preview can establish
- The thesis and strategy approach describe a market view. They do not show whether an entry or exit condition is currently met.
- Technical strategy fields are shared above. Inspect the actual conditions and check when they were evaluated before relying on them.
- No trade count, win rate, or P&L figure is published in this preview. It cannot establish a performance record.
Explore
How CommonQuant researches and tests strategies · Public paper-trading record and its limits · Discover public strategies